Dr. Anna ME Bruynzeel

Amsterdam UMC (formerly VUmc)

Since 2012 Anna ME Bruynzeel is Radiation Oncologist at the VU University Medical Center Amsterdam, the Netherlands. Her areas of interest are Neuro-Oncology, Gastrointestinal tract Oncology, Stereotactic Ablative Radiotherapy and MR-guided Radiotherapy. The latter has recently been introduced in clinical practice using the MRIdian system. Anna belongs to the core team developing protocols and performing MR- guided adaptive treatment including patients with locally advanced pancreatic tumors, prostate cancer and kidney cancer.

dont miss

MR Guided Adaptive Radiation Therapy; three years of clinical experience at VUmc

MR-guided radiation therapy (MRgRT) is a novel and rapidly expanding treatment approach which has been clinically implemented at VUmc Amsterdam since early 2016. In addition to MR-based setup, it offers the potential for real-time target tracking during treatment, marker-less gated delivery, and if indicated, plan re-optimization to generate an optimal ´plan of the day’ for each fraction. MRgRT workflow, benefits, limitations, indications as well as early clinical results will be presented.

Dr. Anna ME Bruynzeel will be speaking in the following theatre:

Theatre 10 - Tuesday 12.30 - 13.00: MR Guided Adaptive Radiation Therapy; three years of clinical experience at VUmc

EVEN MORE SEMINARS

  • Mr Richard Steyn: Speaking at the Oncology Convention

    Mr Richard Steyn
    UK Lung Cancer Coalition / University Hospitals Birmingham NHS Foundation Trust

    Doubling Five-Year UK Lung Cancer Survival to 25% by 2025

  • Corina van den Hurk: Speaking at the Oncology Convention

    Corina van den Hurk
    Netherlands Comprehensive Cancer Organisation

    Hair loss through chemotherapy is not inevitable!

  • Jamie Rae: Speaking at the Oncology Convention

    Jamie Rae
    Throat Cancer Foundation

    The Throat Cancer Foundation; how we changed a government’s mind

  • Clare Hutton & Peter Colley: Speaking at the Oncology Convention

    Clare Hutton & Peter Colley
    Hull & East Yorkshire Hospitals NHS Trust

    The Implementation & Development of IMRT in Hull

  • Stuart Dollow: Speaking at the Oncology Convention

    Stuart Dollow
    Vermilion Life Sciences Ltd

    Reengineering Medicines Development